✦ LIBER ✦

Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor in patients with advanced breast cancer

✍ Scribed by M.E.R. O'Brien; M. Nicolson; A. Montes; A. Tidy; S. Ashley; T.L. Powles

Book ID: 113404268
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 162 KB
Volume: 2
Category: Article
ISSN: 0960-9776
DOI: 10.1016/0960-9776(93)90068-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of mitozantrone, methotrex

Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer

✍ O'Brien, MER; Nicolson, M; Montes, A; Tidy, A; Ashley, S; Powles, TJ 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 706 KB

Combination therapy with mitoxantrone fl

Combination therapy with mitoxantrone fluorouracil, leucovorin, and granulocyte colony-stimulating factor in patients with advanced breast cancer: a phase II study

✍ Panagiotis ginopoulos; Yianis Giannios; Emmanuel Cardamakis; Dimitrios Koukouras 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Treatment of advanced breast cancer with

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor

✍ Karin Haider; Gabriela V. Kornek; Werner Kwasny; Georg Weinländer; Julia Valenca 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 86 KB

Phase I/II study of carboplatin and oral

Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer

✍ Giuseppe Frasci; Giovanni Persico; Giuseppe Perillo; Giuseppe Comella; Pasquale 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

Background. A combination of carboplatin (CBDCA) and oral etoposide is better tolerated than, and as effective as, more aggressive chemotherapy regimens in patients with advanced nonsmall cell lung cancer (NSCLC). A Phase 1/11 study was conducted to determine whether the addition of the granulocyte-

Phase I trial of mitoxantrone and granul

Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies

✍ Joan H. Schiller; Barry Storer; Rhoda Arzoomanian; Kendra Tutsch; Dona Alberti; 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 806 KB

Phase I/II trial of dexverapamil, epirub

Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

✍ W. Scheithauer; G. Kornek; M. Raderer; K. Koperna-Mach; C. Müller; J. Karner; J. 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 407 KB